Table 2.
№ | Material Composition | Size (nm); Shape of ZnO-NPs | Microorganism | Concentration | Effect | Ref. |
---|---|---|---|---|---|---|
1 | Ag2O-NPs | ~170, nanospheres | S. aureus | 20–5000 µg/mL | Bactericidal | [109] |
2 | Ag2O-NPs | 110–120, nanospheres |
A. flavus, A. niger, B. subtilis, C. albicans, E. coli, F. solani, K. pneumonia, M. racemosus, P. aeruginosa, S. aureus |
28.125–112.5 µg/mL | Bacteriostatic Fungistatic | [110] |
3 | Ag2O-NPs | 17.45 |
B. aerius, B. circulans, E. coli, P. aeruginosa |
5–7.5 µg/mL | Bacteriostatic Bactericidal | [113] |
4 | Chitosan/Ag2O NPs suspension | 10–20, nanospheres |
E. coli, S. aureus |
2 µg/mL | Bacteriostatic | [114] |
5 | Polyethylene terephthalate (PET)/Ag2O NPs composite | 50–500, rods, nanospheres | E. coli | Bacteriostatic | [115] | |
6 | Ag2O NPs conjugated with starch in different proportions | 30–110, spherical, faceted |
B. cereus, E. coli, L. onocytogenes, P. vulgaris, P. putida, S. typhymurium, S. aureus, S. saprophyticus |
100 µg/mL | Bacteriostatic | [111] |
7 | Ag2O NPs conjugated with silk fibroin | 15 Nanospheres |
E. coli, M. tuberculosis, S. aureus |
115.9 µg/mL | Bacteriostatic | [112] |
8 | Ag2O NPs mixed with chitosan solution | ~5 |
E. coli, S. aureus, B. subtilis, P. aeruginosa |
~5.8 mg/mL | Bacteriostatic | [116] |
9 | Polyethersulfone (PES)/cellulose acetate (CA)/Ag2O NPs nanocomposite and Cu·PES/CA/Ag2O NP membranes | 20–100 | E. coli | 8 mg/mL | Bacteriostatic | [117] |
10 | PLGA/Ag2O NPs nanocomposite | 35 Nanospheres |
E. coli | 10 µg/mL | Bacteriostatic | [60] |
11 | Fluoroplast/Ag2O NPs nanocomposite | 45 nanospheres |
L. monocytogenes, S. aureus, P. aeruginosa, S. typhimurium |
10 µg/mL | Bacteriostatic Bactericidal |
Present study |